Viz HCM vs Viz SDH
AI Verdict
Choose Viz HCM if…
Choose Viz HCM if your institution aims to significantly reduce the time to diagnosis and treatment for Hypertrophic Cardiomyopathy (HCM) by leveraging AI-powered real-time ECG analysis. This tool is ideal for cardiology departments and health systems focused on streamlining cardiac care coordination and improving patient outcomes for this specific heart condition.
View Viz HCM →Choose Viz SDH if…
Choose Viz SDH if your clinical setting requires rapid, AI-driven detection of acute and chronic subdural hemorrhage from non-contrast CT images to facilitate timely triage and care coordination for neurovascular or neurosurgical emergencies. This tool is best suited for emergency departments and radiology workflows where immediate identification and communication of critical neurological findings are paramount.
View Viz SDH →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz HCM | Viz SDH |
|---|---|---|
| Pricing | Subscription-based | Subscription |
| Deployment | Cloud-based platform, integrated into hospital IT systems (EHR, PACS). | Cloud-based; available on mobile, web, and within the radiology workflow. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools offer mobile-based alerts and notifications to care teams and integrate into existing clinical workflows. Viz HCM mentions EHR and PACS integration, while Viz SDH specifies radiology workflow, mobile, and web. The core user experience for alert delivery and workflow integration appears comparable across both platforms.
Clinical Value
Viz HCMViz HCM explicitly states it 'significantly reducing diagnosis time' for Hypertrophic Cardiomyopathy and is 'clinically validated with extensive real-world evidence and publications'. While Viz SDH provides valuable detection and quantification for subdural hemorrhage, Viz HCM's explicit claims of significant impact and robust validation give it a slight edge in stated clinical value.
Pricing & Value
Viz HCMViz HCM provides clear information regarding CMS reimbursement for specific CPT codes (0764T and 0765T) with a national payment rate, offering a transparent path to financial value for hospitals. Viz SDH's pricing is described more generally as an annual fee based on algorithms and population size, lacking the specific reimbursement details that enhance Viz HCM's value proposition.
Enterprise Readiness
TieBoth Viz HCM and Viz SDH are FDA-cleared, HIPAA compliant, and include a Business Associate Agreement (BAA). They are both cloud-based and designed for integration into hospital IT systems and clinical workflows, indicating a similar high level of enterprise readiness as products from the same vendor.
Innovation
Viz HCMWhile both tools leverage AI innovatively, Viz HCM's application of AI to real-time ECG analysis for Hypertrophic Cardiomyopathy detection is a particularly novel approach to identifying a complex and often underdiagnosed cardiac condition. Viz SDH's AI detection and quantification of subdural hemorrhage are also innovative but operate within a more established domain of AI in medical imaging.
Support & Docs
TieNeither product description provides specific details regarding customer support channels, service level agreements, or documentation availability. As both tools are from the same company (Viz.ai), it is reasonable to assume they would offer comparable enterprise-level support and documentation resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz HCM | Viz SDH |
|---|---|---|
| Name | Viz HCM | Viz SDH |
| Company | Viz.ai | Viz.ai |
| Description | Viz HCM is an FDA-cleared AI tool by Viz.ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time. | AI-powered Viz SUBDURAL (SDH) automatically detects subdural hemorrhage, enables effective triage and optimal care. |
| Target Condition | Hypertrophic Cardiomyopathy (HCM) | Subdural Hemorrhage (SDH) |
| Detection Method | AI-powered ECG analysis | AI detection on non-contrast CT images |
| Key Features | AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection, Real-time disease detection from electrocardiograms, Mobile-based alerts and notifications to multidisciplinary care teams, Automated direction of patients to appropriate care specialists, Reduces time to diagnosis and treatment for HCM, Streamlines cardiac care coordination and clinical workflows, Seamless integration with existing clinical workflows, EHR, and PACS systems, Clinically validated with extensive real-world evidence and publications | Automatic AI detection of acute and chronic subdural hemorrhage on non-contrast CT images, Real-time notification to neurovascular or neurosurgical specialists, Mobile application for receiving alerts and previewing images (for informational purposes), Quantification of subdural collections, including volume, thickness, and midline shift (available with Viz SDH+ module), Integration into existing clinical workflows (e.g., radiology workflow, mobile, web), Supports image sharing and communication among care teams. |
| Specialties | Cardiology, Emergency Medicine, Hospital Medicine | Emergency Medicine, Neurosurgery, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Viz HCM and Viz SDH.
Frequently Asked Questions
More Comparisons
More matchups featuring Viz HCM or Viz SDH
Backers
Who funded each tool's parent company.